Markus Wartmann
9Patents
3h-index
43Co-inventors
57Inventor score
Filing activity: Jan 19, 1999 → Mar 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6302838A | Cancer treatment with epothilones | Human Necessities | 38 | Expired |
| US7875601B2 | Cancer treatment with epothilones | Human Necessities | 4 | Active |
| US6635666B2 | Cancer treatment with epothilones | Human Necessities | 4 | Expired |
| US10130629B2 | Pharmaceutical combinations | Human Necessities | 3 | Active |
| US7612052B2 | Combinations comprising epothilones and pharmaceutical uses thereof | Human Necessities | 1 | Active |
| US7091226B2 | Cancer treatment with epothilones | Human Necessities | 0 | Expired |
| US12083101B2 | Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8008330B2 | Combinations comprising epothilones and pharmaceutical uses thereof | Human Necessities | 0 | Active |
| US7723339B2 | Combination comprising a signal transduction inhibitor and an epothilone derivative | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.